Cerner, Duke Clinical Research Institute Launch New Solution to Innovate Clinical Research

NEXT STORY
Outlook on the Worldwide Oligonucleotide Synthesis Market, 2019 to 2024 – Emerging Asian Markets Present Lucrative Opportunities
PREV STORY
CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA® (iobenguane I 131)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Otsuka and Lundbeck announce improvement of agitation symptoms related to Alzheimer’s-type dementia following treatment with brexpiprazole relative to placebo

Valby, Denmark, 2017-05-02 09:10 CEST (GLOBE NEWSWIRE) -- Valby, Denmark, 2 May 2017 - ...

author_avatar
NASDAQ Market News

Vical Reports First Quarter 2018 Financial and Operational Results

SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial ...

author_avatar
NASDAQ Market News

Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

author_avatar
NASDAQ Market News